Does Arcutis Biotherapeutics (ARQT) Have the Potential to Rally 60.12% as Wall Street Analysts Expect?
Portfolio Pulse from
Analysts predict a potential 60.1% upside for Arcutis Biotherapeutics (ARQT) stock, based on the mean of price targets. Despite the metric's mixed effectiveness, consensus on raising earnings estimates suggests a positive outlook.
November 27, 2024 | 4:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts predict a 60.1% upside for Arcutis Biotherapeutics (ARQT) based on price targets. Consensus on raising earnings estimates supports a positive outlook.
The article highlights a significant potential upside for ARQT based on analysts' price targets and consensus on earnings estimates. This suggests a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100